---
title: "HarborSite: Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases"
url: https://emrr.uz/harborsite?lang=uz
language: uz
updated: 2026-11-19T20:06:51Z
source: emrr (https://emrr.uz)
---

# HarborSite

Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases

[harborsite.com](https://www.harborsite.com/)

- **Soha**: Biotech
- **Joylashuv**: United States

## Tasdiqlangan daromad: hali ulanmagan

HarborSite sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.

[Sizniki boʻlsa, soʻrang](https://panel.emrr.uz/reserve/harborsite)

## Startap haqida

HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.

## Jamoa

- **Erik Aznauryan**, Co-founder and CEO (Asoschi)
- **George Church**, Co-founder and Scientific Advisory Board Chair (Asoschi)
- **Tina Lebar**, Co-founder and Scientific Advisory Board Member (Asoschi)

## Auditoriya

Ijtimoiy tarmoqlardagi kuzatuvchilar

- [X @harborsitetx](https://x.com/harborsitetx)
- [LinkedIn harborsite](https://www.linkedin.com/company/harborsite/)

Profil maʼlumotlari manbasi: Stanbase.

2026-yil 19-noyabr yangilangan

[Bu sahifa Markdown formatida](https://emrr.uz/harborsite.md?lang=uz)

[Tasdiqlangan sahifa ochish](https://emrr.uz/?lang=uz): Stripe, App Store yoki Google Play’ni ikki daqiqada ulang va xuddi shunday sahifaga ega boʻling. emrr har bir raqamni oʻzi oʻqiydi, shuning uchun investorlar raqamlaringizga ishonishi mumkin. $1,000 MRR’gacha bepul.
